Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Suven Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543064 NSE Symbol: SUVENPHAR P/E (TTM) :44.78
ISIN Demat:INE03QK01018 Div & Yield %:0.89 EPS (TTM) :14.99
Book Value (RS) :76.538791 Market Cap (Rs Cr.):17086.4 Face Value (RS) :1
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.050.090.180.20
Long Term Debt-Equity Ratio0.010.030.070.13
Current Ratio2.682.031.552.20
Fixed Assets1.892.091.972.07
Inventory4.475.455.375.02
Debtors7.697.799.206.30
Interest Cover Ratio46.4485.7036.5017.40
PBIDTM (%)47.7458.3345.2948.32
PBITM (%)44.5255.3742.1545.50
PBDTM (%)46.7857.6844.1345.71
CPM (%)35.7545.2333.7035.21
APATM (%)32.5242.2730.5732.39
ROCE (%)34.2851.4538.8345.81
RONW (%)26.4643.1733.4039.71

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)